Status:
COMPLETED
Moesin Expression in Clear Cell Renal Cell Carcinoma
Lead Sponsor:
Sohag University
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
Brief Summary
Renal cell carcinoma (RCC) is the most frequently occurring primary renal neoplasm. There are several histological variants of RCC that are associated with variable prognostic outcomes. Epithelial-mes...
Eligibility Criteria
Inclusion
- All cases of ccRCC.
- Tissue blocks with material adequate for immunohistochemical evaluation.
- All cases with accessible clinical data.
Exclusion
- Cases of renal neoplasms other than ccRCC.
- Patients who received preoperative chemotherapy or radiotherapy.
- Patients with ccRCC who were diagnosed by tru-cut biopsies only and didn't undergo radical operations.
- Cases with insufficient/destructed material.
- Patients with inadequate clinical data.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06055660
Start Date
January 1 2017
End Date
December 31 2021
Last Update
September 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.